Holen Sie sich die Stockscreener-App
1.58
11.27%
0.16
Vorhandelsmarkt:
1.61
0.03
+1.90%
Schlusskurs vom Vortag:
$1.42
Offen:
$1.5
24-Stunden-Volumen:
3.04M
Relative Volume:
1.46
Marktkapitalisierung:
$109.94M
Einnahmen:
$149.16M
Nettoeinkommen (Verlust:
$-39.14M
KGV:
-2.6439
EPS:
-0.5976
Netto-Cashflow:
$-21.18M
1W Leistung:
+13.67%
1M Leistung:
+8.97%
6M Leistung:
-42.12%
1J Leistung:
-57.98%
1-Tages-Spanne:
$1.49
$1.61
1-Wochen-Bereich:
$1.3401
$1.61
52-Wochen-Spanne:
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.58 | 98.80M | 149.16M | -39.14M | -21.18M | -0.5976 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Neuronetics to report fourth quarter 2025 results March 17 - MSN
How The Neuronetics (STIM) Investment Story Is Reset As Analysts Rework Valuation Assumptions - Yahoo Finance
Neuronetics (NASDAQ:STIM) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Neuronetics CFO Steven Pfanstiel to depart; company begins search for successor - MSN
Free cash flow per share of Neuronetics, Inc. – MUN:NRC - TradingView
Neuronetics Stock Drops 2.8% Amid Analyst Downgrades - National Today
Neuronetics (NASDAQ:STIM) Trading Down 2.8%Here's What Happened - MarketBeat
Q3 2025 Neuronetics Inc Earnings Call Transcript - GuruFocus
Neuronetics CFO Steven Pfanstiel to Depart in May - MyChesCo
Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners - The Manila Times
Neuronetics IncPolicy Expanded to Pmhnps i - Moomoo
Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include ... - nrtoday.com
Neuronetics, Inc. Highlights Optum/UHC/UBH TMS Policy Expansion Enabling PMHNPs To Deliver NeuroStar Therapy Across 26 States And Washington D.C - marketscreener.com
[EFFECT] Neuronetics, Inc. SEC Filing - Stock Titan
Neuronetics (STIM) price target increased by 44.44% to 4.42 - MSN
Why is STIM stock rallying 16% after-hours? - MSN
Deal Dispatch: Unilever Buys Grüns, Pershing Square Eyes Universal Music Group, Saks Global Reorganization Plan - Sahm
Malvern’s Neuronetics faces sale pressure from top shareholder - MSN
Deal Dispatch: Unilever Buys Grüns, Pershing Square Eyes Universal Music Group, Saks Global Reorganization Plan - Benzinga
Neuronetics (NASDAQ: STIM) to vote on board, pay and 2026 equity plan - Stock Titan
Major Neuronetics (STIM) holder presses Board to review TMS business - Stock Titan
STIM DEFA14A & SEC Filings - Yahoo Finance Australia
Top shareholder says Neuronetics has 'chronically underperformed,’ pushes sale review - The Business Journals
Neuronetics responds to shareholder letter on valuation By Investing.com - Investing.com India
Neuronetics responds to shareholder letter on valuation - Investing.com
Neuronetics Comments on Letter from Pointillist Family Office - The Manila Times
Neuronetics Announces Chief Financial Officer Transition - National Today
Neuronetics CFO Transition Announced; Company Reaffirms 2026 Financial Guidance and Focus on NeuroStar Advanced Therapy 1 - Minichart
Why Is STIM Stock Rallying 16% After-Hours? - Stocktwits
Neuronetics CFO Steven Pfanstiel to depart in May By Investing.com - Investing.com Canada
Aug Outlook: Is Neuronetics Inc stock a buy or sellEarnings Beat & Community Trade Idea Sharing Platform - baoquankhu1.vn
Neuronetics (STIM) CFO Steven Pfanstiel to Step Down - GuruFocus
STIM Maintains FY26 Financial Outlook with Key Projections - GuruFocus
Neuronetics (STIM) Reaffirms Financial Guidance Amid New Announcement - GuruFocus
Neuronetics (STIM) Shareholder Pushes for Strategic Alternatives Review - GuruFocus
Neuronetics largest shareholder pushes for strategic review By Investing.com - Investing.com Australia
Neuronetics Announces Planned Departure of CFO Steven Pfanstiel and Leadership Transition - citybiz
Neuronetics Announces CFO Transition and Reaffirms 2026 Outlook - TipRanks
Neuronetics Inc. announced that its Chief Financial Officer and Treasurer, Steven E. Furlansteir, has decided to step down. - Bitget
Neuronetics Inc initiates workforce reduction impacting up to 5% of employees - marketscreener.com
Neuronetics announces chief financial officer transition - marketscreener.com
Neuronetics Inc Initiates Workforce Reduction Impacting Up To 5% Of Employees - TradingView — Track All Markets
Neuronetics Announces CFO Exit, Reaffirms Financial Guidance - marketscreener.com
Neuronetics, Inc. Announces Departure of CFO Steven E. Pfanstiel, Confirms Financial Guidance - Quiver Quantitative
CFO exit and cost cuts at Neuronetics (NASDAQ: STIM) 2026 - Stock Titan
Neuronetics, Inc. Announces to Depart Steven E. Pfanstiel as Executive Vice President and Treasurer, Effective May 1, 2026 - marketscreener.com
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):